Products for Research Use Only
RegisterLogin

Palazestrant

CAT: 0013-GTR19212519-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19212519-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Palazestrant (OP-1250) is an orally bioavailable, complete estrogen receptor antagonist (CERAN) and selective ER degrader (SERD) . It potently blocks estrogen-driven proliferation in breast cancer cell lines like MCF-7 and shows antitumor efficacy in vivo models of ER+ breast cancer, supporting its research use for metastatic disease.
CAS Number
2092925-89-6
Product Name Alternative
ER, Estrogen Receptor, EstrogenReceptor, OP1250, OP-1250, OP 1250, progestogenReceptor, progestogen Receptor
Field of Research
Metabolism Research
Purity
97.55% (May vary between batches)
Smiles
C (C (C) (C) F) N1[C@@H] (C2=C (C=3C (N2) =CC=CC3) C[C@H]1C) C4=CC=C (OC5CN (CCC) C5) C=C4
Molecular Formula
C28H36FN3O
Molecular Weight
449.6
Storage Conditions
-20°C
Notes
For research use only.

Alternative Products

CatalogName
C01903-25mgPalazestrant

Popular Products